Source of unique tumour antigens [6]

Source of unique tumour antigens [6]

Detalhes bibliográficos
Principais autores:	Townsend, A, Ohlen, C, Rogers, M, Edwards, J, Mukherjee, S, Bastin, J
Formato:	Journal article
Idioma:	English
Publicado em:	1994

Registros relacionados

Source of unique tumour antigens.
por: Townsend, A, et al.
Publicado em: (1994)

Antigen presentation and the association of class-I molecules.
por: Elliott, T, et al.
Publicado em: (1991)

Goblet cell carcinoid tumours of the appendix: a unique neuroendocrine tumour.
por: Chetty, R
Publicado em: (2008)

Association of class I major histocompatibility heavy and light chains induced by viral peptides.
por: Townsend, A, et al.
Publicado em: (1989)

Pillars article: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989. 340: 443-448.
por: Townsend, A, et al.
Publicado em: (2007)

A mutant cell in which association of class I heavy and light chains is induced by viral peptides.
por: Townsend, A, et al.
Publicado em: (1989)

Expression of tumour-specific antigens underlies cancer immunoediting
por: DuPage, Michel J., et al.
Publicado em: (2012)

DO VACCINIA VIRUS-ENCODED SERPINS INHIBIT ANTIGEN PRESENTATION TO CLASS I-RESTRICTED CTL
por: Blake, N, et al.
Publicado em: (1993)

MHC CLASS-I EXPRESSION IN TRANSPLANTATION TOLERANCE AND PEPTIDE PRESENTATION TO CTL - A MUTANT-CELL THAT FAILS TO PRESENT INTERNALLY DERIVED H-2 RESTRICTED ANTIGENS BUT REMAINS SENSITIVE TO ALLO H-2 SPECIFIC RESPONSES
por: Ohlen, C, et al.
Publicado em: (1989)

The transporters associated with antigen presentation.
por: Townsend, A, et al.
Publicado em: (1993)

COMPARISON OF THE ANTIGEN IN LINEAR IGA BULLOUS DERMATOSIS (LABD) WITH THE ANTIGENS IN EPIDERMOLYSIS BULLOSA-ACQUISITA (EBA) AND BULLOUS PEMPHIGOID (BP) SUGGESTS THAT IT IS A UNIQUE ANTIGEN
por: Pothupitiya, G, et al.
Publicado em: (1987)

Study of antigen processing and presentation of tumour antigen recognised by spontaneous T cell responses in cancer patients
por: Wang, W
Publicado em: (2022)

Mouse H-2(k)-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin
por: Gould, K, et al.
Publicado em: (1987)

Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen.
por: Pothupitiya, G, et al.
Publicado em: (1988)

Fas Ligand breaks tolerance to self antigens, induces tumour immunity and helps to generate tumour-rejecting monoclonal antibodies
por: Simon, A, et al.
Publicado em: (2005)

Empty MHC class I molecules come out in the cold.
por: Ljunggren, H, et al.
Publicado em: (1990)

Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.
por: Cheah, P.L., et al.
Publicado em: (1994)

Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
por: Pinto-Fernandez, A, et al.
Publicado em: (2020)

Uniqueness and non-uniqueness in the Cauchy problem /
por: Zuily, Claude, 1945-
Publicado em: (1983)

Expression of Tumour-Associated Antigens and Characteristics of T Cell Responses in Breast Carcinoma
por: Leong, Pooi Pooi
Publicado em: (2005)

Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
por: Blake, N, et al.
Publicado em: (1995)

Metabolism in the tumour-bone microenvironment
por: Whitburn, J, et al.
Publicado em: (2021)

Antigen processing. A new presentation pathway?
por: Townsend, A
Publicado em: (1992)

The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
por: Kaltsas, G, et al.
Publicado em: (2001)

The uniqueness trap
por: Flyvbjerg, B, et al.
Publicado em: (2025)

Development of a human IgA antibody specific for the tumour antigen TAG-72.
por: Ingram, P, et al.
Publicado em: (1997)

Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences.
por: Townsend, S, et al.
Publicado em: (2001)

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
por: Townsend, A, et al.
Publicado em: (1988)

India’s mass-market clean mobility initiatives and its unique, customized business models for light electric vehicles
por: Mukherjee, M
Publicado em: (2022)

EMPTY MHC CLASS-I MOLECULES COME OUT IN THE COLD
por: Ljunggren, H, et al.
Publicado em: (1990)

Patern - a unique source of technical information : modern methods of access to this information /
por: ASEAN Regional Seminar on Patents - A Unique Source of Technical Information : Modern Methods of Access to This Information (1991 : Kuala Lumpur), et al.
Publicado em: (1991)

The role of tumour-expressed CCR6 and CCR7 in breast cancer metastasis and tumour immunity
por: Tang, Kai Xin
Publicado em: (2020)

Recognition of a human T-lymphocyte differentiation antigen by an IgM monoclonal antibody.
por: Bastin, J, et al.
Publicado em: (1981)

TuBaFrost 6: virtual microscopy in virtual tumour banking.
por: Teodorovic, I, et al.
Publicado em: (2006)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
por: Kaltsas, G, et al.
Publicado em: (2001)

Antigen presentation. Naturally processed peptides.
por: Elliott, T, et al.
Publicado em: (1990)

The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.
por: Backus, K, et al.
Publicado em: (2014)

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
por: Kaltsas, G, et al.
Publicado em: (2001)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
por: Evans-Axelsson, S, et al.
Publicado em: (2012)

Antigen recognition by class I-restricted T lymphocytes.
por: Townsend, A, et al.
Publicado em: (1989)